Fund shareholders of LEXICON PHARMACEUTICALS INC
ISIN US5288723027 · United States
- Fund shareholders
- 30
- Of which ETFs
- 5 25 other funds
- Value held
- 54.5M $
- Share of capital
- 8.2 % of 445M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 14,340,900 | 21.1M $ | 0.03 % | 3.22 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 6,847,451 | 10.7M $ | 0.00 % | 1.54 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 4,331,248 | 6.4M $ | 0.03 % | 0.97 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 3,409,693 | 5M $ | 0.02 % | 0.77 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,447,477 | 3.8M $ | 0.00 % | 0.55 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 921,135 | 1.4M $ | 0.01 % | 0.21 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 861,551 | 1.3M $ | 0.00 % | 0.19 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 548,799 | 806.7K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 515,300 | 757.5K $ | 0.01 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 463,948 | 747K $ | 0.03 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 327,773 | 481.8K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 265,761 | 390.7K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 222,465 | 327K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 150,000 | 241.5K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 122,411 | 191K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 119,718 | 192.7K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 108,648 | 159.7K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 100,212 | 156.3K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 75,689 | 121.9K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 61,875 | 96.5K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 46,275 | 68K $ | 0.48 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 32,783 | 52.8K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 22,679 | 36.5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 11,809 | 18.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TEXAS CAPITAL TEXAS EQUITY INDEX ETF Texas Capital Funds Trust | 9,658 | 15.1K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 8,400 | 13.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 6,264 | 9.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 4,672 | 7.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,900 | 3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 995 | 1.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.48 % | as of Feb 28, 2026 ↗ |
| TEXAS CAPITAL TEXAS EQUITY INDEX ETF Texas Capital Funds Trust | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 0.03 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 0.02 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 0.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 30 | 0 | 36,387,489 | +15.2 % |
| 2026Q1 | 30 | 0 | 31,584,466 | -4.3 % |
| 2025Q4 | 30 | -10 | 32,995,122 | +3.4 % |
| 2025Q3 | 40 | -56 | 31,895,691 | -33.0 % |
| 2025Q2 | 96 | -10 | 47,594,624 | -5.3 % |
| 2025Q1 | 106 | -6 | 50,265,645 | +1.0 % |
| 2024Q4 | 112 | +3 | 49,763,461 | +98.1 % |
| 2024Q3 | 109 | +2 | 25,114,315 | +43.8 % |
| 2024Q2 | 107 | +10 | 17,469,602 | -12.8 % |
| 2024Q1 | 97 | -18 | 20,038,762 | -8.5 % |
| 2023Q4 | 115 | 21,903,722 |
Institutional managers
130 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Artal Group S.A. | 154,734,327 | 241.4M $ | as of Mar 31, 2026 |
| FMR LLC | 45,056,338 | 70.3M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 44,303,518 | 69.1M $ | as of Mar 31, 2026 |
| Sessa Capital IM, L.P. | 17,912,961 | 27.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 7,814,606 | 12.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 4,944,731 | 7.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,322,219 | 5.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,169,111 | 4.9M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 2,665,938 | 4.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,483,182 | 3.9M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 2,376,304 | 3.7M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,121,164 | 3.3M $ | as of Mar 31, 2026 |
| CIBC Bancorp USA Inc. | 1,800,000 | 2.8M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,600,500 | 2.5M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,311,298 | 2M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,199,632 | 1.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,094,901 | 1.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,070,517 | 1.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 964,038 | 1.5M $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 930,089 | 1.5K $ | as of Mar 31, 2026 |
| Ishara Investments LP | 902,000 | 1.4M $ | as of Mar 31, 2026 |
| Hennion & Walsh Asset Management, Inc. | 848,138 | 1.3M $ | as of Mar 31, 2026 |
| MACKENZIE FINANCIAL CORP | 772,677 | 1.2M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 750,000 | 1.2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 526,103 | 820.7K $ | as of Mar 31, 2026 |
Declared shareholders of LEXICON PHARMACEUTICALS INC
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Invus, L.P. and 17 others | 39.40 % | 175,156,062 | as of Apr 30, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Fund shareholders of LEXICON PHARMACEUTICALS INC". https://titelia.com/en/stocks/lexicon-pharmaceuticals-inc-US5288723027